Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria

Omalizumab was a safe and effective corticosteroid alternative for maintaining long-term remission of symptoms in these patients. Treatment intervals required individual patient-by-patient determination. The drug did not seem to alter the natural history of the disease.